Glancy Prongay & Murray LLP Announces Investigation on Behalf of DarioHealth Corp.
NEW YORK--(BUSINESS WIRE)--Jan 7, 2021--
Glancy Prongay & Murray LLP (“GPM”) announces its investigation on behalf of DarioHealth Corp. (Nasdaq: DRIO) concerning the Company and its directors’ and officers’ possible violations of state laws.
If you purchased DarioHealth stock, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Tom Kennedy, of GPM, 230 Park Avenue, Suite 530, New York, NY 10169 at firstname.lastname@example.org, or at 212-682-5340. If you inquire by email please include your mailing address, telephone number, and the number of shares purchased and held.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com:https://www.businesswire.com/news/home/20210107005906/en/
CONTACT: Glancy Prongay & Murray LLP
Tom Kennedy, 212-682-5340
John Belanger, 310-201-9150
KEYWORD: UNITED STATES NORTH AMERICA NEW YORK
INDUSTRY KEYWORD: LEGAL PROFESSIONAL SERVICES
SOURCE: Glancy Prongay & Murray LLP
Copyright Business Wire 2021.
PUB: 01/07/2021 05:09 PM/DISC: 01/07/2021 05:09 PM